12:00 AM
 | 
Oct 25, 2004
 |  BioCentury  |  Finance

Gilead's pipeline

Gilead's pipeline

Compound Indication Status
Emtriva...

Read the full 50 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >